An evaluation of the clinical usefulness of amifostine (YM-08310), radioprotective agent. A double-blind placebo-controlled study. 2. Abdominal and pelvic tumor

Journal of Japan Society for Cancer Therapy

Volumn 20, Issue 5, 1985, Pages 994-1001

  Niibe, H ^a   Takahashi, I ^a   Miyaishi, K ^a   Mitsuhashi, N ^b   Maehara, Y ^b   Nakajima, N ^b   Suto, H ^b   Saito, Y ^b   Yamakawa, M ^b   Sugiyama, S ^b  

^a GUNMA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; PLACEBO;

ABDOMINAL CANCER; BONE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG THERAPY; HUMAN; PELVIS CANCER; PREVENTION; RADIATION PROTECTION; RADIOTHERAPY; THERAPY;

ADULT; AGED; AMIFOSTINE; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGANOTHIOPHOSPHORUS COMPOUNDS; OVARIAN NEOPLASMS; PELVIC NEOPLASMS; RADIATION-PROTECTIVE AGENTS; UTERINE CERVICAL NEOPLASMS;

EID: 0021864054     PISSN: 00214671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)